Catalyst Wire Dossier Catalyst Wire Dossier

Byannli

paliperidone palmitate · Janssen-Cilag International N.V.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Byannli, covering 2024-07-22 to 2026-06-10. Get the full timeline:

Most recent: EMA Authorised: Byannli (previously Paliperidone Janssen-Cilag International) (paliperidone palmitate) — Janssen-Cilag International N.V.

See pricing